Zota Health Care posts 83.86% revenue surge in FY26
Healthcare

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores

  • By IPP Bureau | May 25, 2026
Zota Health Care Limited has delivered a sharp jump in performance for FY26, reporting a consolidated revenue from operations of Rs. 53,865.75 lakh, up 83.86% year-on-year, driven by aggressive retail expansion and strong growth in its Davaindia pharmacy chain.
 
The company also reported consolidated EBITDA of Rs. 2,597.73 lakh for FY26, marking a significant turnaround from the previous year’s loss of Rs. 366.51 lakh.
 
FY26 consolidated gross profit rose to Rs. 32,468.90 lakh, compared to Rs. 15,567.13 lakh in FY25, reflecting a 108.57% increase, with gross margin expanding to 60.28%.
 
The biggest growth driver remained Zota’s Davaindia network, which expanded aggressively across India. The chain now stands at 2,579 stores nationwide, after adding 997 new stores in FY26 alone, the company’s highest-ever annual store addition.
 
In Q4FY26 alone, Zota added 248 new stores (218 COCO and 30 FOFO).
 
Operational momentum also strengthened: Quarterly footfall rose to 55.07 lakh, Quarterly GMV jumped to Rs. 14,035 lakhs, nearly doubling year-on-year, Average wallet spend increased across store formats.
 
For the full year FY26, Davaindia recorded: 182.47 lakh footfall, Rs. 45,706 lakhs GMV.
 
Segment snapshots: Davaindia sales surged to Rs. 41,741.47 lakh in FY26, compared to Rs. 18,621.40 lakh in FY25. Domestic and herbal segments also contributed steady gains, while export sales via SEZ moderated slightly.
 
Zota continued to deepen its integrated healthcare and retail strategy: The company appointed Bollywood actor Akshay Kumar as brand ambassador for its “UGO Generic” platform, aimed at scaling affordable medicines across India through a hybrid B2B and B2C model.
 
Through subsidiary Everyday Herbal Beauty Care Limited, Zota launched a new retail format called “All Day Stores” (ADS), offering over 430 SKUs across personal care, OTC, nutraceuticals, and household essentials.
 
The company increased its stake in EHBCL to 87.78%, investing Rs. 19.47 crore via rights issue, strengthening backward integration.
 
Chairman Ketan Kumar Zota described FY26 as a “defining year” for the company, citing rapid expansion and stronger execution across its retail ecosystem.
 
He highlighted milestones including a Rs. 350 crore QIP, expansion into new retail formats, and partnerships with high-profile brand ambassadors including Akshay Kumar, Suniel Shetty, and M.S. Dhoni.
 
The company reiterated its long-term ambition of scaling to 5,000 Davaindia stores by FY29.

Other Related stories

Startup

Digitization